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Similarly to metazoans, yeast cells can exhibit several characteris-
tics of apoptosis, including chromatin condensation, DNA break-
age,flipping of phosphatidylserine to the outer leaflet of the plasma
membrane, accumulation of reactive oxygen species (ROS), and
release of pro-death factors such as cytochrome c or Endonucle-
ase G from mitochondria. Yeast programed cell death has been
shown to occur in response to a variety of stimuli, such as oxida-
tive stress, exposure to acetic acid, and expression of mammalian
pro-apoptotic proteins. This program is also inherent to the yeast
life cycle, as aged mother cells and cells exposed to pheromone also
display an apoptotic and necrotic phenotype. Yeast therefore com-
prises a conserved core programed cell death process that shares
several regulators with mammalian cells, which play major roles in
the pathogenesis of human diseases. At the same time, it lacks many
of the cell death regulators that have evolved in higher eukaryotes,
probably due to the invention of multicellularity. The simplicity of
the yeast model allows elucidating the basic molecular pathways
of programed cell death without interference from multifaceted
regulation, due to various protein isoforms or cellular specificity
often observed in studies using mammalian systems. In addition,
yeast heterologous expression systems offer the opportunity to
exploit the individual functional and mechanistic properties of
mammalian apoptotic regulators.
This special issue gathers recent studies enhancing the under-
standing of PCD and its deregulation, relevant in human patholo-
gies and aging. These include review, mini-review, original
research, perspective, and hypothesis and theory articles deal-
ing with the identification of previously uncharacterized pro-
teins and the function of different cellular compartments and
organelles involved in PCD and aging, as well as the exploitation
of humanized yeasts to untangle the role of apoptotic regulators.
Yeast has long been established as a valuable model system
to study conserved biological processes of relevance to human
health, and several reviews address the importance of studying
endogenous yeast mechanisms to understand human pathologies,
particularly cancer and aging. Mollinedo stresses the relevance
of lipid rafts in cell physiology and the advantages of the yeast
model system to address unsolved questions regarding their role
in survival and cell death signaling in mammalian cells, which
will impact the design of lipid raft-mediated approaches to treat
human pathologies caused by dysfunction of survival and cell
death processes (1).
Tosato and co-workers review two yeast models relevant
for cancer formation and progression, one mimicking genome
instability, a hallmark of cancer, and another metabolic features
of cancer cells, including the Warburg effect (2), whereas Maz-
zoni and colleagues hypothesize that their newly developed yeast
clonal life span assay will provide a valuable complement to aging
studies (3).
Kitanovic and co-workers showed that intracellular acidifi-
cation resulting from accumulation of acetic acid in exhausted
medium, causes cellular energetic deficiency and nutrient starva-
tion (4). The role of acetic acid, one the main alcoholic fermen-
tation sub-products, as an extrinsic mediator of both processes,
and the key function of acetic acid detoxification enzyme Ach1p
for mitochondrial functionality, is discussed by Orlandi and
co-workers (5).
Oxidative stress is frequently associated with cell death and
severe human pathologies. Farrugia and Balzan discuss oxidative
stress in yeast, specifically sources of ROS, their molecular targets,
and consequences of ROS accumulation, such as up-regulation
of antioxidant defenses, activation of both pro-survival and PCD
mechanisms, including apoptosis, autophagy, and necrosis, as well
as the relevance of ROS in yeast aging (6).
Several articles review the role of organelles in PCD. Guarag-
nella and colleagues discuss the role of mitochondria and of
mitochondrial proteins with an attributed role in the execution
and regulation of PCD in yeast, underscoring the use of yeast cells
to unravel the mechanisms behind human diseases associated with
mitochondrial dysfunctions (7).
An increasing body of evidence shows that organelles other
than mitochondria are also involved in PCD and aging scenarios.
The function of the endoplasmic reticulum (ER) in PCD is dis-
cussed by Austriaco. He identifies the link between the ER and
mitochondria during PCD, and the mechanisms leading to ER
fragmentation associated with ER stress, as two emerging research
areas (8).
It has recently been proposed that peroxisomes can also con-
tribute to oxidative stress, and therefore foster aging and cell
death, though through not completely understood mechanisms.
Manivannan and co-authors review the current knowledge on the
role of peroxisomes in these degenerative processes focusing on
data obtained in yeast, and pinpoint future research lines, namely
the study of peroxisomal unfolded protein response; the selective
inheritance of peroxisomes during replicative aging, and the role of
peroxisomal dynamics versus functionality during chronological
and replicative aging (9).
Two reviews also address the evolutionary aspects of PCD
mechanisms. Shlezinger et al. stress the differences in PCD mech-
anisms between yeast and metazoans, as well as the similarities
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and differences of the PCD machinery between single and multi-
cellular fungi, highlighting the contribution of filamentous yeast
species to apoptosis studies (10). Shresta and Megeney analyze the
non-death role of metacaspases in the regulation of cell cycle and
proteostasis and protein aggregate formation, and discuss how the
cellular utility and roles of the caspase family may have evolved
(11). Ren and co-workers studied the relation between checkpoint
malfunction and cell death, and suggest that Bir1 plays a concerted
role in both the spindle assembly checkpoint and in preventing cell
death (12).
Several articles also underscore the use of humanized yeasts
to untangle complex biological processes. Van Rossom and co-
workers provide an example by using the yeast system to dis-
sect apoptotic properties of the human tumor suppressor pro-
tein DFNA5, mapping a domain of DFNA5 that can induce
mitochondria-mediated PCD in yeast, as well as a mutation that
abrogates it (13). Braun reviews the use of a yeast neurotoxic-
ity model to understand the role of mitochondrial dysfunction
in neurodegenerative disorders, particularly their involvement on
the prevention or execution of cell death (14). Clapp et al. review
the use of genetic screens in yeast using cDNA expression libraries
generated from mammalian cells to identify novel PCD regulators,
particularly anti-apoptotic components (15).
The data gathered by the studies discussed in this special issue
and by many others in the field are promising and foster the use
of this simple eukaryotic model system to further unravel the
mysteries of cell aging and PCD.
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